Radiosurgery and stereotactic radiotherapy with cyberknife system for meningioma treatment
Objective The aim of this work was to evaluate the impact of stereotactic radiosurgery/fractionated stereotactic radiotherapy with the Cyberknife system on local disease control, clinical outcome and toxicity in patients with meningioma, according to the site and histological grade of lesion. From January 2013 to April 2017, 52 patients with intracranial meningiomas were treated with the Cyberknife system. Twenty-four patients had undergone previous surgery: 38% gross total resection, 10% subtotal resection; 27 patients underwent no surgery; 22 patients had a recurrence of meningioma. Methods Radiosurgery was used for lesions smaller than 2 cm, stereotactic radiotherapy for lesions larger than 2 cm, or smaller but close to a critical site such as the optical chiasm, optic pathway or brainstem. Results Local control and clinical outcomes were analysed. Median follow-up was 20 months: six patients died, one after re-surgery died from post-surgical sepsis, three from heart disease. Progression-free survival had a mean value of 38.3 months and overall survival of 41.6 months. We evaluated at 12 months 28 patients (100% local control); at 24 months 19 patients (89% local control); at 36 months nine patients (89% local control). At baseline, 44/52 patients (85%) were symptomatic: 19 visual disorders, 17 motor disorders, six hearing disorders, 10 headache and six epilepsy. Visual symptoms remained unchanged in 52%, improved in 32%, resolved in 16%. Headache was improved in 40%, resolved in 10%, unchanged in 50%. Epilepsy was resolved in 17%, unchanged in 33%, worsened in 33%. Conclusions Stereotactic radiosurgery/fractionated stereotactic radiotherapy with Cyberknife provides a good local disease control, improving visual, hearing and motor symptoms.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2018 |
|---|---|
| Erschienen: |
2018 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:31 |
|---|---|
| Enthalten in: |
The neuroradiology journal - 31(2018), 1 vom: 03. Feb., Seite 18-26 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Di Franco, Rossella [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Cyberknife |
|---|
| Anmerkungen: |
Date Completed 25.07.2018 Date Revised 08.04.2022 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1177/1971400917744885 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM278714021 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM278714021 | ||
| 003 | DE-627 | ||
| 005 | 20231225021248.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2018 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1177/1971400917744885 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0929.xml |
| 035 | |a (DE-627)NLM278714021 | ||
| 035 | |a (NLM)29206077 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Di Franco, Rossella |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Radiosurgery and stereotactic radiotherapy with cyberknife system for meningioma treatment |
| 264 | 1 | |c 2018 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 25.07.2018 | ||
| 500 | |a Date Revised 08.04.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Objective The aim of this work was to evaluate the impact of stereotactic radiosurgery/fractionated stereotactic radiotherapy with the Cyberknife system on local disease control, clinical outcome and toxicity in patients with meningioma, according to the site and histological grade of lesion. From January 2013 to April 2017, 52 patients with intracranial meningiomas were treated with the Cyberknife system. Twenty-four patients had undergone previous surgery: 38% gross total resection, 10% subtotal resection; 27 patients underwent no surgery; 22 patients had a recurrence of meningioma. Methods Radiosurgery was used for lesions smaller than 2 cm, stereotactic radiotherapy for lesions larger than 2 cm, or smaller but close to a critical site such as the optical chiasm, optic pathway or brainstem. Results Local control and clinical outcomes were analysed. Median follow-up was 20 months: six patients died, one after re-surgery died from post-surgical sepsis, three from heart disease. Progression-free survival had a mean value of 38.3 months and overall survival of 41.6 months. We evaluated at 12 months 28 patients (100% local control); at 24 months 19 patients (89% local control); at 36 months nine patients (89% local control). At baseline, 44/52 patients (85%) were symptomatic: 19 visual disorders, 17 motor disorders, six hearing disorders, 10 headache and six epilepsy. Visual symptoms remained unchanged in 52%, improved in 32%, resolved in 16%. Headache was improved in 40%, resolved in 10%, unchanged in 50%. Epilepsy was resolved in 17%, unchanged in 33%, worsened in 33%. Conclusions Stereotactic radiosurgery/fractionated stereotactic radiotherapy with Cyberknife provides a good local disease control, improving visual, hearing and motor symptoms | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Cyberknife | |
| 650 | 4 | |a Meningiomas | |
| 650 | 4 | |a fractionated stereotactic radiotherapy | |
| 650 | 4 | |a stereotactic radiosurgery | |
| 700 | 1 | |a Borzillo, Valentina |e verfasserin |4 aut | |
| 700 | 1 | |a Ravo, Vincenzo |e verfasserin |4 aut | |
| 700 | 1 | |a Falivene, Sara |e verfasserin |4 aut | |
| 700 | 1 | |a Romano, Francesco Jacopo |e verfasserin |4 aut | |
| 700 | 1 | |a Muto, Matteo |e verfasserin |4 aut | |
| 700 | 1 | |a Cammarota, Fabrizio |e verfasserin |4 aut | |
| 700 | 1 | |a Totaro, Giuseppe |e verfasserin |4 aut | |
| 700 | 1 | |a Ametrano, Gianluca |e verfasserin |4 aut | |
| 700 | 1 | |a Rossetti, Sabrina |e verfasserin |4 aut | |
| 700 | 1 | |a Cavaliere, Carla |e verfasserin |4 aut | |
| 700 | 1 | |a D' Aniello, Carmine |e verfasserin |4 aut | |
| 700 | 1 | |a Iovane, Gelsomina |e verfasserin |4 aut | |
| 700 | 1 | |a Porricelli, Maria Assunta |e verfasserin |4 aut | |
| 700 | 1 | |a Berretta, Massimiliano |e verfasserin |4 aut | |
| 700 | 1 | |a Botti, Gerardo |e verfasserin |4 aut | |
| 700 | 1 | |a Starace, Luigi |e verfasserin |4 aut | |
| 700 | 1 | |a Salvia, Enrico La |e verfasserin |4 aut | |
| 700 | 1 | |a Facchini, Gaetano |e verfasserin |4 aut | |
| 700 | 1 | |a Muto, Paolo |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t The neuroradiology journal |d 2006 |g 31(2018), 1 vom: 03. Feb., Seite 18-26 |w (DE-627)NLM213791560 |x 2385-1996 |7 nnns |
| 773 | 1 | 8 | |g volume:31 |g year:2018 |g number:1 |g day:03 |g month:02 |g pages:18-26 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1177/1971400917744885 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 31 |j 2018 |e 1 |b 03 |c 02 |h 18-26 | ||